Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
Reggiani
P
P
Istituto di Chirurgia Sperimentale e dei Trapianti-Centro Trapianto di Fegato, IRCCS Ospedale Maggiore di Milano, Università degli Studi di Milano, Italy.
Rossi
G
G
Latham
L
L
Caccamo
L
L
Gatti
S
S
Maggi
U
U
Melada
E
E
Paone
G
G
Doglia
M
M
Vannelli
A
A
Fassati
L R
LR
D000284:Administration, Oral; D000328:Adult; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D016559:Tacrolimus / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D016559:Tacrolimus; D008775:Methylprednisolone